StockWatch
·
Pharmaceuticals
Board Meeting28 Jul 2026, 09:24 am

Ipca Laboratories Board Meeting on Aug 13, 2026 for Q1 Results

AI Summary

Ipca Laboratories Ltd has announced that its Board of Directors will convene on August 13, 2026. The primary agenda for this meeting is to consider and approve the standalone and consolidated unaudited financial results for the first quarter ended June 30, 2026. The company also confirmed that the trading window for insiders will remain closed from July 1, 2026, until 48 hours after the declaration of these financial results, extending to August 15, 2026.

Key Highlights

  • Board meeting scheduled for August 13, 2026.
  • To approve Q1 FY27 standalone and consolidated results.
  • Trading window closure extended until August 15, 2026.
  • Disclosure made as per SEBI Listing Obligations and Disclosure Requirements.